Live from the NIH registry
Studies recruiting near Staten Island right now
Top 25 of 4,271 recruiting studies, sorted by proximity — each links to its official registry page
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Prematurity
N/A
Interventional 120 participants sought
Mount Sinai Hospitals — New York, New York (11.8 mi)
· Sponsor: Icahn School of Medicine at Mount Sinai
DBS for Depression
Treatment Resistant Depression
Phase 1
Interventional 20 participants sought
Zucker Hillside Hospital — Queens, New York (17.8 mi)
· Sponsor: Northwell Health
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Laura and Isaac Perlmutter Cancer Center at NYU Langone — New York, New York (11.8 mi)
· Sponsor: National Cancer Institute (NCI)
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Harlem Prevention Center — New York, New York (11.8 mi)
· Sponsor: Westat
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Cancer, Period Problem
Phase 2
Interventional 60 participants sought
Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York (11.8 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
NYC Research Inc — Long Island City, New York (15.3 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Ophthalmic Consultants of Long Island — Oceanside, New York (27.0 mi)
· Sponsor: Boehringer Ingelheim
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Phase 3
Interventional 893 participants sought
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street). — New York, New York (11.8 mi)
· Sponsor: Pfizer
Mobile CBT for Middle Aged and Older Adults
Anxiety Disorders and Symptoms, Depressive Symptoms
N/A
Interventional 60 participants sought
Weill Cornell Medicine — New York, New York (11.8 mi)
· Sponsor: Weill Medical College of Cornell University
FUS Etoposide for DMG
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant
Phase 1
Interventional 10 participants sought
Columbia University Irving Medical Center — New York, New York (11.8 mi)
· Sponsor: Columbia University
E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness
Cigarette Smoking
N/A
Interventional 60 participants sought
NYU Langone Health — New York, New York (11.8 mi)
· Sponsor: NYU Langone Health
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
Montefiore Einstein Medical Center — The Bronx, New York (23.6 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0108) — New York, New York (11.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
Colorectal Cancer
N/A
Interventional 880 participants sought
Columbia University Irving Medical Center — New York, New York (11.8 mi)
· Sponsor: Columbia University
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
Stroke, Cerebrovascular Accident
N/A
Interventional 150 participants sought
Hackensack Meridian Health - JFK Johnson Rehabilitation Institute — Edison, New Jersey (14.5 mi)
· Sponsor: Hackensack Meridian Health
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Plasma Cell Myeloma Refractory
Phase 1
Interventional 87 participants sought
Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400001 — Hackensack, New Jersey (21.6 mi)
· Sponsor: Sanofi
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Metastatic Solid Tumors
Phase 1
Interventional 600 participants sought
Memorial Sloan Kettering Cancer Center — New York, New York (11.8 mi)
· Sponsor: Erasca, Inc.
PENG vs Femoral Block for Hip Fracture Analgesia
Hip Fractures
N/A
Interventional 352 participants sought
Weill Cornell Medicine — Manhattan, New York (16.8 mi)
· Sponsor: Weill Medical College of Cornell University
MDMA-Assisted Therapy for Mental Healthcare Providers
Mental Wellbeing
Phase 1
Interventional 30 participants sought
The Parsons Research Center for Psychedelic Healing — New York, New York (11.8 mi)
· Sponsor: Rachel Yehuda
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
The Tisch Cancer Institute/Mount Sinai — New York, New York (11.8 mi)
· Sponsor: C4 Therapeutics, Inc.
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Atlantic Eye Physicians — Eatontown, New Jersey (20.5 mi)
· Sponsor: VisionCare, Inc.
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey (17.2 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Modern Migraine, MD — New York, New York (11.8 mi)
· Sponsor: AbbVie
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
Icahn School of Medicine at Mount Sinai — New York, New York (11.8 mi)
· Sponsor: GentiBio, Inc
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — New York, New York (11.8 mi)
· Sponsor: AstraZeneca